Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;22(3):213-249.
doi: 10.5217/ir.2023.00050. Epub 2024 Jul 29.

Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023

Affiliations

Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023

Hsu-Heng Yen et al. Intest Res. 2024 Jul.

Abstract

Ulcerative colitis (UC) is a chronic inflammation of the gastrointestinal tract and is characterized by alternating periods of inflammation and remission. Although UC incidence is lower in Taiwan than in Western countries, its impact remains considerable, demanding updated guidelines for addressing local healthcare challenges and patient needs. The revised guidelines employ international standards and recent research, emphasizing practical implementation within the Taiwanese healthcare system. Since the inception of the guidelines in 2017, the Taiwan Society of Inflammatory Bowel Disease has acknowledged the need for ongoing revisions to incorporate emerging therapeutic options and evolving disease management practices. This updated guideline aims to align UC management with local contexts, ensuring comprehensive and context-specific recommendations, thereby raising the standard of care for UC patients in Taiwan. By adapting and optimizing international protocols for local relevance, these efforts seek to enhance health outcomes for patients with UC.

Keywords: Consensus; Guidelines; Management; Taiwan; Ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Wong JM and Wei SC are editorial board members of the journal but were not involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.

Figures

Fig. 1.
Fig. 1.
Recommended algorithm for the treatment of UC. a1 g/day. b≥2 g/day. c≥1 g/day. d9 mg/day. e1.0–2.5 mg/kg/day. f0.45–1.5 mg/kg/day. gAnti-tumor necrosis factor (infliximab, adalimumab; golimumab), vedolizumab, ustekinumab, JAK inhihitors (tofacitinib, upadacitinib) or ozanimod. 5-ASA, 5-aminosalicylic acid; Tx, treatment; MMX, multi-matrix; UC, ulcerative colitis; AZA, azathioprine; 6-MP, 6-mercaptopurine; IV, intravenous.
Fig. 2.
Fig. 2.
Recommended algorithm for the treatment of acute severe ulcerative colitis (UC). aComplete blood count, C-reactive protein, electrolytes, liver enzymes, hepatitis B virus, hepatitis C virus, etc; bStool culture, Clostridium difficile toxin, viruses; cMethylprodcisionle 1 mg/ kg/day or 60 mg/day, maximally, or hydrocortisone 100 mg×4 times daily, maximally; dTreatment failure, C-reactive protein >4.5 mg/dL & blood stool 3–8 times/day or bloody stool >8 times/day. TB, tuberculosis; CT, computed tomography; IV, intravenous; 5-ASA, 5-aminosalicylic acid.

References

    1. Feuerstein JD, Cheifetz AS. Ulcerative colitis: epidemiology, diagnosis, and management. Mayo Clin Proc. 2014;89:1553–1563. - PubMed
    1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54. - PubMed
    1. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–1794. - PubMed
    1. Wei SC, Lin MH, Tung CC, et al. A nationwide populationbased study of the inflammatory bowel diseases between 1998 and 2008 in Taiwan. BMC Gastroenterol. 2013;13:166. - PMC - PubMed
    1. Chuang CH, Lin SH, Chen CY, Sheu BS, Kao AW, Wang JD. Increasing incidence and lifetime risk of inflammatory bowel disease in Taiwan: a nationwide study in a low-endemic area 1998-2010. Inflamm Bowel Dis. 2013;19:2815–2819. - PubMed

LinkOut - more resources